News 25.03.19

Lead Pharma Announces Start of Phase I Clinical Trials with SAR441169 Candidate Treatment for Psoriasis

Sanofi, Lead Pharma’s collaborative partner in the development of SAR441169, successfully initiated first human dosing with this novel RORγt Inverse Agonist...

Read more
News 14.03.19

BioConnection further strengthens its position in the (bio) pharmaceutical CMO business by adding a Flexible GMP area to its current capabilities.

BioConnection opens this month, after an intensive engineering and validation program its Flexible GMP area. The area consists of several...

Read more
News 26.02.19

CEO Monique van Scherpenzeel – “I love to get my hands dirty in the lab”

Monique van Scherpenzeel (1981) exchanged the University for the Business world. In April 2018 she started her own company, GlycoMScan,...

Read more
News 19.02.19

A cup of coffee with…. Inez de Greef (3D-PharmXchange)

Inez de Greef, co-owner and founder of 3D-PharmXchange, started the company together with Ronald van der Geest because they find...

Read more
News 19.02.19

PharmSupport starts SME GxP expertise center

The Life Sciences & Health sector is characterized by complex and demanding quality legislation and regulations (GxP, collective name for,...

Read more
News 12.02.19

Tissue-type analysis included in Oncolines™ cancer cell line profiling

The approval label of many drugs specifically states use in cancer of a certain tissue type, for instance, breast or lung. In any approach to precision medicine, cancer lineage should therefore be taken into account. NTRC’s Oncolines™ cancer cell line profiling service1,2 now includes such tissue-type analysis, indicating whether drugs or drug candidates show preferential activity in a certain cancer tissue type.

Read more
News 11.02.19

Aduro Announces First Patient Dosed in Phase 1 Study of ADU-S100 (MIW815) in Combination with YERVOY (ipilimumab) for the Treatment of Relapsed and Refractory Melanoma

Aduro Biotech announced that the first patient has been dosed in a Phase 1 trial of ADU-S100 (MIW815), a novel...

Read more
News 05.02.19

André van de Sande ambassador and advisor to Pivot Park

André van de Sande has recently been appointed as ambassador and advisor to the Pivot Park in Oss. Together with...

Read more
News 30.01.19

Foundation laid for new Q fever vaccine

Three years of research at, among others, Innatoss Laboratories in Oss laid the foundation for a new Q fever vaccine....

Read more